MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
BusinessWeek
August 7, 2006
Arlene Weintraub
McKesson's Booster Shot McKesson Corp. holds the unenviable distinction of being one of the world's biggest yet least profitable companies. The problem: huge sales, tiny profits. High-margin tech products could help. mark for My Articles similar articles
The Motley Fool
October 26, 2005
Stephen D. Simpson
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. mark for My Articles similar articles
The Motley Fool
May 20, 2004
Tom Taulli
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth. mark for My Articles similar articles
The Motley Fool
January 30, 2006
Brian Gorman
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 1, 2004
W.D. Crotty
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. mark for My Articles similar articles
The Motley Fool
May 6, 2008
Steven Renaldi
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. mark for My Articles similar articles
BusinessWeek
November 24, 2003
Roger O. Crockett
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. mark for My Articles similar articles
The Motley Fool
January 2, 2004
Alyce Lomax
A Bitter Pill for Amerisource Veterans ditch Amerisource for rival; investors punish the entire pharmaceutical distribution industry. mark for My Articles similar articles
The Motley Fool
November 7, 2007
Billy Fisher
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. mark for My Articles similar articles
The Motley Fool
December 10, 2004
Brian Gorman
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. mark for My Articles similar articles
The Motley Fool
October 28, 2004
Brian Gorman
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. mark for My Articles similar articles
The Motley Fool
August 24, 2011
Brandon Glenn
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? mark for My Articles similar articles
The Motley Fool
January 21, 2005
Rich Duprey
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. mark for My Articles similar articles
The Motley Fool
October 8, 2007
Billy Fisher
McKesson Expands Its Empire A new acquisition strengthens the company's presence in the cancer drug market. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 13, 2006
Ryan Fuhrmann
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. mark for My Articles similar articles
The Motley Fool
June 28, 2005
Brian Gorman
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. mark for My Articles similar articles
The Motley Fool
November 9, 2005
W.D. Crotty
McKesson Fattens Its Margins The pharma distributor turns in an outstanding second quarter. Because McKesson is a broadly based supplier, it avoids the roller-coaster impact that specific drug successes and failures have on drug-developer stocks. mark for My Articles similar articles
The Motley Fool
August 3, 2006
Ryan Fuhrmann
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. mark for My Articles similar articles
The Motley Fool
January 26, 2004
Alyce Lomax
Amerisource's Fightin' Words Wholesale drug distributor AmerisourceBergen's first-quarter profits rise, but will a fight with veterans end peacefully? mark for My Articles similar articles
The Motley Fool
May 6, 2005
W.D. Crotty
McKesson's New Pep Pill The drug wholesaler reports strong fourth-quarter results as it moves to a fee-for-service model. mark for My Articles similar articles
The Motley Fool
May 2, 2008
Steven Renaldi
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it. mark for My Articles similar articles
The Motley Fool
June 27, 2011
Brandon Glenn
Cardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other) Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health has had an apparent change of opinion. mark for My Articles similar articles
The Motley Fool
November 8, 2011
Brandon Glenn
Cardinal Health Looks to Build China Business, but Has Long Way to Go For pharmaceuticals distributor Cardinal Health, China represents a world of opportunity. mark for My Articles similar articles
The Motley Fool
October 25, 2004
Tom Taulli
McKesson Gets Pain Relief Drug distributors would like to forget 2004. But this may mean bargains for investors. mark for My Articles similar articles
The Motley Fool
January 26, 2007
Billy Fisher
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note. mark for My Articles similar articles
The Motley Fool
December 22, 2010
Seth Jayson
Here's How McKesson Is Making So Much for You With TTM margins all at a five-year high, McKesson looks like it's doing great. mark for My Articles similar articles
The Motley Fool
April 7, 2011
Brandon Glenn
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. mark for My Articles similar articles
The Motley Fool
October 12, 2004
W.D. Crotty
A Bargain in Drug Distribution? D&K Healthcare Resources' stock surprises investors, but the drop brings a favorable valuation. mark for My Articles similar articles
The Motley Fool
October 6, 2008
Brian Orelli
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated. mark for My Articles similar articles
The Motley Fool
July 28, 2004
Brian Gorman
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. mark for My Articles similar articles
The Motley Fool
May 2, 2005
Brian Gorman
Cardinal Health Perks Up The drug distribution company is working through its problems, which should make for a brighter fiscal 2006. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 30, 2008
Brian Orelli
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? mark for My Articles similar articles
The Motley Fool
October 21, 2010
Anand Chokkavelu
6 Health-Care Stocks Near 52-Week Lows Here are the largest health care equipment and services companies (by market cap) that are hugging 52-week lows: Medtronic... Covidien... Stryker... Becton, Dickinson and Company... McKesson... Cardinal Health... mark for My Articles similar articles
Entrepreneur
November 2006
Nichole L. Torres
Loud and Clear Boost sales by selling customers on your competitive advantage. mark for My Articles similar articles
The Motley Fool
August 5, 2005
Stephen D. Simpson
Can This Cardinal Sing? If Cardinal Health succeeds in its plans to return more capital to shareholders, this could become an interesting income play. This stock is worth keeping an eye on for the future. mark for My Articles similar articles
The Motley Fool
September 2, 2009
Brian Orelli
Should You Buy This Spinoff? Cardinal Health kicks its baby out of the nest. mark for My Articles similar articles